Signal transducer and activator of transcription 1 (STAT1) signaling potentiates antitumor immune responses downstream of type I (IFNα/β) and II (IFNγ) interferons (IFNs), both within tumor cells and immune cells26,27. The gene discussed is STAT1; the disease is neoplasm.